DNA damage repair profiling of esophageal squamous cell carcinoma uncovers clinically relevant molecular subtypes with distinct prognoses and therapeutic vulnerabilities

Ning Zhao,Zicheng Zhang,Qiang Wang,Lin Li,Zichao Wei,Hongyan Chen,Meng Zhou,Zhihua Liu,Jianzhong Su
DOI: https://doi.org/10.1016/j.ebiom.2023.104801
IF: 11.205
2023-09-19
EBioMedicine
Abstract:Summary Background DNA damage repair (DDR) is a critical process that maintains genomic integrity and plays essential roles at both the cellular and organismic levels. Here, we aimed to characterize the DDR profiling of esophageal squamous cell carcinoma (ESCC), investigate the prognostic value of DDR-related features, and explore their potential for guiding personalized treatment strategies. Methods We analyzed bulk and single-cell transcriptomics data from 377 ESCC cases from our institution and other publicly available cohorts to identify major DDR subtypes. The heterogeneity in cellular and functional properties, tumor microenvironment (TME) characteristics, and prognostic significance of these DDR subtypes were investigated using immunogenomic analysis and in vitro experiments. Additionally, we experimentally validated a combinatorial immunotherapy strategy using syngeneic mouse models of ESCC. Findings DDR alteration profiling enabled us to identify two distinct DDR subtypes, DDR active and DDR silent , which exhibited independent prognostic values in locoregional ESCC but not in metastatic ESCC. The DDR silent subtype was characterized by an inflamed but immune-suppressed microenvironment with relatively high immune cell infiltration, abnormal immune checkpoint expression, T-cell exhaustion, and enrichment of cancer-related pathways. Moreover, DDR subtyping indicates that BRCA1 and HFM1 are robust and independent prognostic factors in locoregional ESCC. Finally, we proposed and verified that the concomitant triggering of GITR or blockade of BTLA with PD-1 blockade or cisplatin chemotherapy represents effective combination strategies for high-risk locoregional ESCC tumors. Interpretation Our discovery of DDR-based molecular subtypes will enhance our understanding of tumor heterogeneity and have significant clinical implications for the therapeutic and management strategies of locoregional ESCC. Funding This study was supported by the National Key R&D Program of China ( 2021YFC2501000 , 2022YFC3401003 ), National Natural Science Foundation of China (82172882), the Beijing Natural Science Foundation ( 7212085 ), the CAMS Innovation Fund for Medical Sciences (2021-I2M-1-018, 2021-I2M-1-067), the Fundamental Research Funds for the Central Universities ( 3332021091 ), and the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences ( 2019PT310027 ).
medicine, research & experimental
What problem does this paper attempt to address?